Research Analysts Set Expectations for DAWN Q1 Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for shares of Day One Biopharmaceuticals in a note issued to investors on Thursday, April 3rd. HC Wainwright analyst A. Maldonado now expects that the company will earn ($0.37) per share for […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for shares of Day One Biopharmaceuticals in a note issued to investors on Thursday, April 3rd. HC Wainwright analyst A. Maldonado now expects that the company will earn ($0.37) per share for […]
